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The hydrogen peroxide sensitivity of cells lacking two pro-
teins, Sco1 andCox11, important in the assembly of cytochrome
c oxidase (CcO), is shown to arise from the transient accumula-
tion of a pro-oxidant heme A-Cox1 stalled intermediate. The
peroxide sensitivity of these cells is abrogated by a reduction in
either Cox1 expression or hemeA formation but exacerbated by
either enhanced Cox1 expression or heme A production arising
from overexpression of COX15. Sco1 and Cox11 are implicated
in the formation of the CuA and CuB sites of CcO, respectively.
The respective wild-type genes suppress the peroxide sensitivi-
ties of sco1 and cox11 cells, but no cross-complementation is
seen with noncognate genes. Copper-binding mutant alleles of
Sco1 andCox11 that are nonfunctional in promoting the assem-
bly of CcO are functional in suppressing the peroxide sensitivity
of their respective null mutants. Likewise, human Sco1 that is
nonfunctional in yeast CcO assembly is able to suppress the per-
oxide sensitivity of yeast sco1 cells. Thus, a disconnect exists
between the respiratory capacity of cells and hydrogen peroxide
sensitivity. Hydrogen peroxide sensitivity of sco1 and cox11
cells is abrogated by overexpression of a novel mitochondrial
ATPase Afg1 that promotes the degradation of CcO mitochon-
drially encoded subunits. Studies on the hydrogen peroxide sen-
sitivity in CcO assembly mutants reveal new aspects of the CcO
assembly process.
Assembly of cytochrome c oxidase (CcO),2 the terminal
enzyme of the mitochondrial respiratory chain, is a sophisti-
cated, multistep process that involves a number of auxiliary
proteins (1–3). Some of these proteins have a specific role, such
as heme A biosynthesis or translation of mitochondrial-
encoded subunits. Other assembly proteins act as chaperones
or facilitators of the assembly process. Among them are a series
of copper-binding proteins implicated in the assembly of the
two copper centers of CcO. Copper metallation of CcO occurs
within the mitochondrial intermembrane space (IMS) and is
mediated by metallochaperone proteins. Cox17 is a key copper
donor to two accessory proteins, Sco1 and Cox11, to form the
CuA and CuB copper centers in the mature CcO complex (4).
Sco1 and Cox11 are each integral membrane proteins with
C-terminal globular domains protruding into the IMS (5). The
globular domain of Sco1 possesses a thioredoxin fold consisting
of a central four-stranded  sheet covered with flanking helices
(6–8). Two notable features of Sco proteins are a conserved
pair of cysteinyl residues within a CXXXC motif and a con-
served histidyl residue that forms a Cu(I) binding site. Muta-
tions of the Cys or His residues abrogate Cu(I) binding and lead
to a nonfunctional CcO complex and respiratory-deficient cells
(9). Thus, the in vivo function of Sco1 correlates with Cu(I)
binding. The globular domain of Cox11 adopts an immuno-
globulin-like  fold. Three conserved Cys residues are candi-
date ligands for the Cu(I) ion. Mutation of these Cys residues
attenuatesCu(I) binding aswell asCcO function (10). Thus, like
Sco1, the residues in Cox11 important for Cu(I)-binding corre-
late with in vivo function, suggesting that Cu(I) binding is
important in Cox11 function. These observations are consist-
ent with the postulate that Cu(I) ions donated to Sco1 and
Cox11 via Cox17 are subsequently transferred to Cox2 and
Cox1 for assembly of the CuA and CuB sites, respectively. The
function of both Sco1 and Cox11 was predicted to be solely
attributable to formation of CcO copper centers (11).
Although recombinant Sco1 is isolated with bound Cu(I)
ions in copper-supplemented bacterial cultures, attempts to
crystallize the Cu(I)-Sco1 complex failed in a number of labo-
ratories (7, 8, 12). The structure of the Cu(I)-Sco1 complex was
subsequently achieved byNMRspectroscopy (13). The inability
to crystallize Sco1 with a bound Cu(I) led some investigators to
speculate that Sco1might function in CcO assembly independ-
ent of Cu(I) binding (7, 12). The structural resemblance of Sco1
to peroxiredoxins and thioredoxins raised the possibility that
Sco proteinsmay function as a thiol:disulfide oxidoreductase to
maintain the CuA site cysteines in the reduced state ready for
metallation (14). Alternatively, Sco1 was suggested to function
as a redox switch, in which oxidation of Cu(I) to Cu(II) induces
release of the Cu(II) ion, thereby permitting the two thiolates to
participate in a peroxidase reaction. In support of a redox role
for Sco1, sco1 yeast cells were observed to be sensitive to
hydrogen peroxide (7). In addition, cox11 cells, but not
cox17 or cox4 cells, are also peroxide-sensitive (15, 16). The
apparent selective peroxide sensitivity of sco1 and cox11
cells suggested that Sco1 andCox11 have amitochondrial func-
tion independent of coppermetallation. To elucidate themech-
anism of the peroxide sensitivity of sco1 and cox11 cells, we
surveyed a wide array of yeast mutants and isolated genetic
suppressors.We show that the hydrogen peroxide sensitivity of
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sco1 and cox11 cells arises from a pro-oxidant Cox1 assem-
bly intermediate involving Cox1 and heme A.We demonstrate
that both Sco1 and Cox11 have protein chaperone roles in sta-
bilizingCox1 andCox2 chains in addition to their copper trans-
fer functions. These studies on hydrogen peroxide sensitivity in
CcO assembly shed further insight into the assembly process.
MATERIALS ANDMETHODS
Strains and Growth Media—The S. cerevisiae strains used in
this study are listed in supplemental Table 1. S. cerevisiae cells
were grown in YP (1% yeast extract,
2% peptone) with either 2% glucose,
raffinose, galactose, lactate, or glyc-
erol as a carbon source or synthetic
minimal medium supplemented
with respective amino acids and 2%
glucose or glycerol. For cloning and
plasmid amplification, Escherichia
coli strain DH5 was used. The cul-
ture medium used was as described
(17).
Plasmids and Constructs—For all
manipulations with DNA fragments
and plasmids, standard procedures
were used (17). Yeast cellswere trans-
formed as described (18). Plasmids
carrying either theCOX11 gene or its
mutated forms (COX11-C111A,
COX11-C208A,COX11-C210A) (10)
were used for complementation tests.
Similarly, plasmids that carry the
SCO1 gene or its mutated versions
(SCO1-C148A, SCO1-C152A, SCO1-
C181A, SCO1-C216A) were used (9).
We also used the Sco1/Cox11 chi-
mera, consisting of the N-terminal
part of Cox11, including the trans-
membrane helix, fused with the
C-terminal moiety of Sco1 (19) for
complementation tests. The human
SCO1 open reading frame was PCR-
amplified from templates described
previously (20) and cloned into
pRS426vectorunder theMET25pro-
moter (21). For overexpression of
COX15, the open reading frame was
subcloned into pRS426 under the
MET25 promoter.
Hydrogen Peroxide Treatment of
Yeast Cells—Cells of the respective
strains or transformants were
grown in full or selective liquid
medium containing 2% glucose, at
30 °C.When cells reachedmidexpo-
nential growth, hydrogen peroxide
was added to a final concentration
of 0.5, 1, or 6 mM. After a 2-h incu-
bation at 30 °C, cells were serially diluted and plated onto YPD
plates. Heme synthesis was inhibited with 0.5 mM succinyl ace-
tone (Sigma) for a 3-h period prior to the addition of hydro-
gen peroxide.
Hydrogen Peroxide Sensitivity Suppressor Screen—A high
copy genomic library constructed using the total DNA isolated
from S. cerevisiae with five times genome coverage was used to
screen for high copy suppressors of peroxide sensitivity of
cox11nullmutant. Each transformantwas individually cultured
in 96-well plates. Grown cells were treated as described above
FIGURE 1.Hydrogen peroxide sensitivity of sco1 and cox11 cells. A, sco1 (top) or cox11 (bottom) cells
containing an empty vector or plasmid expressing either wild-type (WT) SCO1 or COX11, respectively, or
mutant forms thereof, unable to bind Cu(I), were grown to midexponential phase and incubated with () or
without () low (1mM) or high (6mM)H2O2 for 2 h at 30 °C. Respective serial dilutionswere spotted onto plates
containing 2%glucose and incubated for 36–48h at 30 °C. B, sco1or cox11 cells transformedwith an empty
vector or plasmid expressing either yeast or human SCO1, yeastCOX11, or chimera consisting of theN-terminal
portionof Sco1, including its transmembranedomain, and theC-terminal part of Cox11. Cellswere treated and
grownasdescribed above.C, cells of various respiratory-deficient strains alongwith thewild-type controlwere
grown on plates containing glucose. A sterile filter disc containing 50%H2O2 (3l) was placed in themiddle of
the plate. Lengths of the streaks were measured after 2 days of incubation at 30 °C and compared with the
length of wild-type strain, which was set as 100%. The diagram represents the results of three independent
experiments.
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and stamped onto a YPD plate. Obtained colonies were ana-
lyzed and run through a second round of screening to exclude
the false positives. Ten thousand transformants were analyzed.
Retrieved AFG1 open reading frame was amplified from the
total genomic DNA of wild-type BY4741 strain with the addi-
tion of a single Myc tag at the 3-end and cloned into pRS426
vector under control of theMET25 promoter.
Mitochondrial Localization Studies—Mitochondria were
isolated as described (22). CcO activities were determined as
described (23). Alkaline extraction of proteins was performed
as described (24) using 0.1 M Na2CO3, pH 10.5 or 11.5. Isolated
mitochondria were treated with proteinase K (10 mg/ml) and
analyzed as described (25).
Assessment of Carbonylation Levels—Cells of the respective
strains were grown overnight at 30 °C to middle exponential
phase. Each culture was split into halves; one was treated with
H2O2 as described above, and the second half served as a con-
trol. Carbonylation levels were assessed using the OxyBlotTM
protein oxidation detection kit (Serologicals Corp., Norcross,
GA) according to the manufacturer’s manual.
In Vivo Labeling of Yeast Cells—Cells of the respective strains
or transformants were grown and pulse-labeled with [35S]me-
thionine in the presence of cycloheximide as described (26)
for 30 min. Following the labeling,
cells were incubated at 37 °C, and
samples were collected at time
points 0, 10, 30, and 60 min,
resolved by SDS-PAGE, and ana-
lyzed by autoradiography. Densi-
tometric analysis was performed
using Image J 1.35 software (avail-
able on the World Wide Web at
image.bio.methods.free.fr/ijd-
oshell.html).
RESULTS
As shown previously, yeast cells
lacking Sco1 or Cox11 are sensitive
to hydrogen peroxide (15, 16). Cells
were incubated in the presence or
absence of hydrogen peroxide for
2 h at 30 °C prior to plating out the
cultures on rich growth medium in
the absence of peroxide. Both
mutants are growth-compromised
in a pretreatment with 1 or 6 mM
hydrogen peroxide (Fig. 1, A and B).
The mutants are not sensitive to
paraquat (16). Cells lacking Cox11
are slightly, but reproducibly, more
sensitive to peroxide than cells lack-
ing Sco1 (Fig. 1, A and C). The per-
oxide sensitivity of sco1 and
cox11 cells is manifest only in cells
harvested in log phase, since sta-
tionary cultures are largely resistant
to 6 mM hydrogen peroxide (data
not shown). To establish that the
FIGURE 2. Hydrogen peroxide sensitivity of cells devoid of mitochondri-
ally encoded CcO subunits. Cells of the strains depleted formitochondrially
coded COX1, COX2, or COX3 genes as well as cells lacking translational activa-
tors Pet309 or Pet111 and CcO assembly proteins Cox20 or Cox10 were
treated and grown as described in Fig. 1.WT, wild type.
FIGURE 3. Changes in mitochondrial translation affect H2O2 sensitivity of yeast cells. A, cox11, sco1, and
cox20 cellsweregrown tomidexponential phaseand incubatedwith (CAP) orwithout (CAP) chloramphenicol
(8mg/ml)prior to incubationwithhydrogenperoxide.Thencellsweretreatedandgrownasdescribedinthe legend
toFig.1.B,cox11cellswereturnedintothe rhostateby intensivetreatmentwithethidiumbromide.Theobtained
cells alongwith the cox11 strainwith intactmitochondrial genomewere incubatedwith () or without () 6mM
H2O2 and grown as described in the legend to Fig. 1. C, cox11, cox14, and double cox11 cox14mutant cells
were incubated with () or without () 0.5 mM H2O2 for 2 h at 30 °C, serially diluted, and spotted onto plates
containing2%glucoseand incubated for36–48hat30 °C.D,cox11,pet309, anddoublecox11pet309mutant
cells were grown to midexponential phase and incubated with () or without () 1 or 6 mM H2O2 and grown as
described in the legend to Fig. 1.WT, wild type.
Heme-Cox1 Intermediate
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peroxide sensitivity arose from the deletion of either SCO1 or
COX11, transformants of the null strains with the wild-type
genewere tested for hydrogen peroxide sensitivity. SCO1 trans-
formants of sco1 cells and COX11 transformants of cox11
cells were insensitive to hydrogen peroxide (Fig. 1, A and B).
Surprisingly, Sco1mutants with substitutions of the two Cu(I)-
binding Cys residues, Cys148 and Cys152, were also effective in
suppressing the peroxide sensitivity of sco1 cells (Fig. 1A).
Likewise, Cox11 mutants with substitutions of three Cu(I)-
binding Cys residues also were effective in suppressing the
peroxide sensitivity of cox11 cells (Fig. 1A).Whereas cells har-
boring these mutant alleles of Sco1 and Cox11 are peroxide-
resistant, the cells remain respiratory-deficient, since CcO
assembly is impaired. The suppression of sco1 and cox11
cells is protein-specific. High copy SCO1 cannot suppress the
peroxide sensitivity of cox11 cells, and overexpression of
COX11 fails to suppress the peroxide sensitivity of sco1 cells
(Fig. 1B). However, a Sco1/Cox11 chimera consisting of the
Sco1 N-terminal segment, including the transmembrane
domain fused to the C-terminal globular domain of Cox11, was
a weak suppressor of the peroxide sensitivity of both sco1 and
cox11 cells (Fig. 1B).
Human SCO1 fails to complement the respiratory defect of
yeast sco1 cells, yet human SCO1 does reverse the peroxide
sensitivity of sco1 cells (Fig. 1B). Taken together, these data
demonstrate that peroxide resistance requires one aspect of the
Sco1 and Cox11 proteins but not the copper binding aspect.
To uncover the source of the peroxide sensitivity in CcO
assembly mutants, we screened a variety of additional CcO
mutants for peroxide sensitivity. Cells lacking Cox1 are respi-
ratory-deficient but resistant to 6mM peroxide (Figs. 1C and 2).
Cells lacking Cox2 or Cox3 are resistant to 1 mM peroxide but
show sensitivity at 6 mM (Figs. 1C and 2). Cells lacking the
FIGURE 4. Solvent-exposed channel in the hemeA-Cox1 complex. A, view
of Cox1 (light gray ribbon) taken from the bovine CcO structure (47) and the
Cox1 subunit with hemeA/A3 (black space fill). The hememoieties are packed
in a channel-like cavity, partially exposed to the IMS, and accessible to H2O2.
The structureswere generated by Pymol software. B, Cox2 (space-filled) packs
onCox1 (ribbon) tomask theexposedhemes. Theblack space-filledhemes are
no longer visible. C, schematic of the pro-oxidant heme A-Cox1 transient
intermediate (scheme 1). We proposed that Cox11 transiently docks on Cox1
during CuB site formation, thereby sterically blocking the accessible channel
in Cox1. Scheme 2 depicts amodel of Cox2 requiring Sco1 to induce a confor-
mational state in Cox2 capable of docking properly on Cox1 shielding the
heme Amoieties as shown in scheme 3. ROS, reactive oxygen species. FIGURE 5. Involvement of heme in the peroxide sensitivity.A, inhibition ofheme synthesis reverses the hydrogen peroxide sensitivity of cox11 cells.
Cells were treated with 0.5 mM succinyl acetone (SA) in YPD for 3 h prior to
incubation with 1mMH2O2. B, effect of overexpression of COX15 (designated
HC for high copy) on peroxide sensitivity of assembly mutants. Cells were
incubated with 0.5 mM H2O2 as described in A.WT, wild type.
FIGURE 6. Protein carbonylation levels are increased in Cox11-depleted
mitochondria.Wild-type (WT) or cox11 cellsweregrown tomidexponential
phase, and each culture was split into two halves, one left untreated () and
the other incubated with 1 mM H2O2 for 2 h at 30 °C (). Mitochondria were
isolated and derivatized with 2,4-dinitrophenylhydrazine (DNPH), separated
by SDS-PAGE (10% gel), and analyzed by immunoblotting using anti-2,4-di-
nitrophenylhydrazine antibodies. Anti-porin antibodies were used to ensure
equal loadingof samples. The fourderivatizedbandsexhibitingan increase in
intensity (marked by asterisks in the left panel) in cox11 cells were analyzed
by densitometry to quantify the summation of intensities, and this summa-
tionwas comparedwith the corresponding gel areas inwild-type cells (right).
Heme-Cox1 Intermediate
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translational activator Pet309 or Pet111 required for Cox1 and
Cox2 translation, respectively, are resistant to hydrogen perox-
ide. Cells lacking Cox10, which functions in hemeA formation,
are resistant to peroxide, but cells lacking the Cox20 chaperone
for Cox2 proteolytic maturation are partially sensitive to expo-
sure to hydrogen peroxide (Figs. 1C and 2). One scenario is that
cells lacking Cox20, Cox11, or Sco1 accumulate a transient
intermediate in CcO assembly that may confer hydrogen per-
oxide sensitivity.
Studies were undertaken to determine whether the pro-oxi-
dant contains a CcOmitochondrial- encoded subunit. The per-
oxide sensitivity of sco1, cox11, and cox20 cells is partially
reversed by preincubation of those cultures with chloramphen-
icol for 10 min prior to exposure to peroxide (Fig. 3A). The
presence of chloramphenicol inhibits mitochondrial protein
synthesis. Chloramphenicol failed to suppress the peroxide
sensitivity of ctt1 cells lacking the cytosolic Ctt1 catalase. In
addition, the peroxide sensitivity of cox11 cells is abrogated by
conversion of cox11 cells to a rho state (Fig. 3B).
Cox1 is implicated as a component of the pro-oxidant, since
cells lacking Cox2 or Cox3 are partially sensitive, whereas cells
lacking Cox1 are peroxide-resistant (Figs. 1C and 2). To sub-
stantiate the role of Cox1 in the peroxide sensitivity, COX14
was deleted, creating the cox11cox14 double null strain.
Cells lacking Cox14 hyperaccumulate nascent Cox1 chains
(27). Cells lacking both Cox11 and Cox14 are hypersensitive to
hydrogen peroxide, showing growth impairment with 0.5 mM
H2O2 (Fig. 3C). The role of Cox1was substantiated by the dem-
onstration that the peroxide sensitivity of cox11 cells is atten-
uated by disruption of the Cox1
translational activator Pet309. The
cox11pet309 double mutant was
peroxide-resistant, consistent with
Cox1 being a component of the pro-
oxidant (Fig. 3D).
The observed peroxide sensitivity
may arise with the generation of a
pro-oxidant or the disruption of a
redox system. One candidate pro-
oxidant would be the heme A3 moi-
ety in Cox1. Heme A3 has an open
coordination site thatmay yield per-
oxidase activity. HemeA is probably
inserted into Cox1 prior to the addi-
tion of Cox2 in the assembly path-
way (28). The structure of Cox1 has
an open channel from the IMS side
of the IM, where heme A insertion
may occur (Fig. 4A). The peroxide
sensitivity of cox11 cells may arise
from the transient accumulation of
a heme A-Cox1 intermediate (Fig.
4C, 1). The solvent accessibility of
this putative intermediate may
enable the heme to catalyze forma-
tion of the hydroxyl radical pro-ox-
idant. Residual heme A is observed
in cells lacking Cox11 or Sco1 (29).
If a heme A-Cox1 intermediate is the pro-oxidant, the
observed peroxide sensitivity of cox11 cells should be reversed
if heme A formation is blocked and exacerbated if heme A pro-
duction is increased. The inhibition of heme synthesis in
cox11 cells by the addition of 0.5 mM succinyl acetone abro-
gated the sensitivity to 1 mM hydrogen peroxide (Fig. 5A). Fur-
thermore, overexpression of COX15, which is known to signif-
icantly increase the levels of heme A in CcO assembly mutants
(30), exacerbated the hydrogen peroxide sensitivity of cox11
and sco1 cells (Fig. 5B). A growth defect was observedwith 0.5
mMH2O2 in the overexpressor cells. Overexpression ofCOX15
also induced mild sensitivity in wild-type cells to 0.5 mM H2O2
but curiously no sensitivity in shy1 cells. The lack of peroxide
sensitivity in shy1 cells is consistent with a defect in heme A3
insertion in these cells. Rhodobacter cells lacking ShyI are com-
promised in heme A3 insertion (31).
The accumulation of a heme A-Cox1 pro-oxidant interme-
diate in cox11 cells may result in generalized reactive oxygen
damage. Wild-type and cox11 cells were cultured in the pres-
ence of 1 mM H2O2 for 2 h at 30 °C for isolation of mitochon-
dria. The accumulation of carbonylated proteins was assessed
by immunoblotting after dinitrophenyl hydrazone derivatiza-
tion. cox11 cells showed nearly 2-fold enhancement in car-
bonylation, consistent with enhanced reactive oxygen sensitiv-
ity (Fig. 6).
Multicopy suppressors of the peroxide sensitivity of
cox11 cells were isolated. Null cells transformed with a high
copy DNA library were screened for clones able to propagate
in 6 mM hydrogen peroxide. Two plasmid-borne suppressors
FIGURE 7.AFG1and STR2 are specific high copy suppressors of theH2O2 sensitivity of sco1 and cox11
mutants.A, sco1 or cox11 cells containing empty vector or plasmids expressing high copy suppressorAFG1
or STR2were treated with H2O2, and serial dilutions were spotted as described in the legend to Fig. 1. B, serial
dilutions of sco1 cells transformed with either an empty vector or plasmids expressing SCO1, AFG1, or STR2
genes were spotted onto plates containing 2% glucose or 2% lactate, glycerol. C, cells lacking cytochrome c
peroxidase (ccp1) and cytosolic catalase (ctt1) transformed with an empty vector or plasmids expressing
either AFG1 or STR2were treated with hydrogen peroxide and grown as described above.WT, wild type.
Heme-Cox1 Intermediate
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were isolated (Fig. 7A). Overexpression of STR2 orAFG1was
found to suppress the peroxide sensitivity but not the respi-
ratory deficiency of both sco1 and cox11 cells (Fig. 7B).
Str2 is a cystathionine -synthase that converts cysteine into
cystathionine (32). A C-terminal green fluorescent protein
fusion of Str2 was reported to localize to the cytoplasm and
nucleus (33). Afg1 is a putative mitochondrial ATPase (34).
STR2 but not AFG1 was found to strongly suppress the per-
oxide sensitivity of ccp1 cells lacking cytochrome c perox-
idase localized to the IMS. Neither gene suppressed the per-
oxide sensitivity of cells lacking the cytosolic Ctt1 catalase
(Fig. 7C). Str2 may have a general role in protecting mito-
chondria from peroxide stress. Overexpression of Afg1 was
also found to suppress the peroxide sensitivity of cox20
cells, suggesting that it has some specificity to the peroxide
sensitivity of CcO assembly mutants. Since Afg1 was selec-
tive in its suppression of mutants in the CcO assembly path-
way, we chose to restrict our focus to Afg1.
Cells lacking Afg1 showed a modest growth impairment on
glycerol medium at 37 °C, and both CcO and the bc1 complex
activities are reduced (supplemental Fig. 1). AMyc-taggedAfg1
fusion was found to localize within the mitochondrion and be
membrane-associated (Fig. 8). The fusion protein was insensi-
tive to proteinase K inwholemitochondria andmitoplasts, sug-
gesting that the protein faces the matrix side of the IM. Afg1
resembles themitochondrial iAAA (Yme1) andmAAA (Yta10/
Yta12) proteases but lacks the characteristic zinc protease
domain (supplemental Fig. 2). The ATPase domain of Afg1 is
important for its ability to suppress cox11 cells (data not
shown).
To address whether Afg1 functions in degradation of Cox1,
Cox2, and Cox3, cox11 cells in the presence or absence of
AFG1were pulse-labeled with [35S]methionine in the presence
of cycloheximide, permitting only labeling of themitochondrial
translation products. The presence of AFG1 did not alter the 35S
incorporation into Cox1, Cox2, or Cox3 during the pulse phase of
the reaction (Fig. 9A), butAFG1 did accentuate the diminution in
labeled Cox1, Cox2, and Cox3 during the chase (Fig. 9, B–D).
AFG1 had no effect on the turnover of Cob in the bc1 com-
plex (Fig. 9E) or Var1 (data not shown). Thus, although Afg1
lacks a zinc protease domain, it facilitates the degradation of
Cox1, Cox2, and Cox3 in cox11 cells. This observation was
consistent with the peroxide sensitivity of cox11 cells aris-
ing from a Cox1 intermediate.
DISCUSSION
A subset of mutants that impair assembly of cytochrome c
oxidase show amarked sensitivity to hydrogen peroxide in log-
arithmically growing cells (15, 16). The peroxide sensitivity is
disconnected from the respiratory capacity of cells, since cells
lacking the mitochondrial genome are resistant to hydrogen
peroxide. The mutants exhibiting the peroxide sensitivity
appear to generate a transient and low abundant pro-oxidant
assembly intermediate consisting of Cox1. Cells lacking Cox1
or its translational activator Pet309 are peroxide-resistant, but
cells stalled in CcO assembly due to an inability to generate the
CuB site in Cox1 (cox11mutant), an inability to fold ormature
Cox2 (cox20 and sco1 mutants), or an absence of Cox2 or
Cox3 result in varying levels of peroxide sensitivity. Since the
peroxide sensitivity of cox11 cells is suppressed by the deple-
tion of Cox1 (pet309 mutant) or inhibition of mitochondrial
protein synthesis, nascent Cox1 chains appear to be deleterious
with respect to hydrogen peroxide sensitivity. We postulate
that the transient accumulation of unassembled Cox1 results in
peroxide sensitivity. Importantly, these studies on hydrogen
peroxide sensitivity in CcO assembly shed insight into the
assembly process.
Residual levels of unassembled Cox1 exist in CcO mutant
yeast strains (35), including cox11 cells (27). The pro-oxidant
is probably a hemeA-Cox1 complex. Cells unable to formheme
A are peroxide-resistant (cox10 cells or cells treated with suc-
cinyl acetone), and cells overexpressing COX15 are hypersen-
sitive to hydrogen peroxide. The lack of peroxide sensitivity in
shy1 cells overexpressing Cox15 is consistent with a reported
role of ShyI in hemeA insertion. Rhodobacter cells lacking ShyI
are compromised in heme A3 insertion (31). Heme A3 is the
likely pro-oxidant in Cox1, since only heme A3 has an open
coordination site. Thus, shy1 cells would be peroxide-resis-
tant if yeast ShyI also functions in hemeA3 insertion, and that is
what we observe. The candidate heme A3-Cox1 unassembled
pro-oxidant intermediate is probably so transient in nature that
FIGURE 8. Innermitochondrial membrane localization of Afg1. A, isolated
mitochondria of a strain expressing C-terminally Myc-tagged Afg1 (M, lane 1)
were treated with 0.1 M Na2CO3 and fractionated by high speed centrifuga-
tion. Obtained pellet (P, lanes 2 and 4) and supernatant (S, lanes 3 and 5)
fractions were analyzed by immunoblotting using antibodies against Myc
epitope, matrix protein Sod2, and IM-anchored protein Cox2. B, intact mito-
chondria (lanes 1,2, and4) ormitoplasts (Swelling; lane3) isolated fromastrain
expressing Afg1-Mycwere incubatedwith (lanes 2, 3, and 5) or without (lanes
1 and 4) proteinase K (PK). In lanes 4 and 5, mitochondria were lysed with 1%
Triton X-100 (TX-100) prior to incubation with proteinase K. Proteins were
separated by SDS-PAGE and analyzed by Western blot using antibodies spe-
cific for Myc-tag, matrix protein Sod2, and intramitochondrial space protein
Ccp1.
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visualizing it biochemically would be nearly impossible. Its
existence is largely corroborated by genetic evidence.
Heme A insertion occurs in Cox1 prior to the addition of
Cox2. An open channel exists in Cox1 throughwhich hemeA is
probably inserted from the IMS side of the IM (Fig. 4A). The
channel is sterically blocked upon the insertion of Cox2 (Fig.
4B). The globular domain of Cox2 packs onto Cox1, occluding
the accessible channel. CuB site formation in Cox1 occurs
either in synchrony or sequentially with heme A insertion.
Assembly of the CuB site is precluded in cox11 cells, and these
cells are peroxide-sensitive. We propose that the globular
domain of Cox11 projecting into the IMS is able to transiently
occlude the Cox1 channel, thereby yielding peroxide resistance
(Fig. 4C). This putative Cox11-Cox1 complex is expected to
mediate Cu(I) transfer to the Cox1 CuB site through ligand
exchange reactions. However, the ability of Cox11 to mediate
peroxide resistance is unrelated to the ability of Cox11 to bind
Cu(I). Cox11 may bind and stabilize Cox1 through transient
interactions involving both the C-terminal globular domain
and its transmembrane domain. We show presently that the
Cox11 transmembrane domain is important for the ability of
Cox11 to efficiently confer peroxide resistance. A transient
interaction of Cox11 with Cox1 may stabilize a conformer of
Cox1 that has less solvent accessibility to the heme A3.
Peroxide sensitivity arising from a transient accumulation of
heme A3-Cox1 is consistent with the observed peroxide sensi-
tivity of sco1, cox20, and cox2 cells. The lack of Sco1 or
Cox20 may destabilize Cox2 sufficiently that it fails to stably
interact with Cox1, leading to peroxide sensitivity (Fig. 4C).
Whereas the lack of Cox2may be expected to result in accumu-
lation of the pro-oxidant Cox1 intermediate, only modest per-
oxide sensitivity is observed in cox2 cells, and pet111 cells
are peroxide-resistant. Cells containingmutant alleles ofCOX2
with mutations in the 5-untrans-
lated region showed the expected
diminution in Cox2 nascent chains
but also reduced Cox1 nascent
chains (36). Likewise, cells lacking
Pet111 show the expected loss of
Cox2 translation and also diminu-
tion in Cox1 translation (37). We
confirmed that pet111 cells have
attenuated Cox1 translation (data
not shown). Furthermore, overex-
pression of Pet111 results in a dim-
inution in translation of Cox1 (38),
suggesting that translational activa-
tors function in a balanced manner.
Thus, the limited peroxide sensitiv-
ity observed in cox2 and pet111
cells probably arises from reduced
levels of the Cox1 intermediate.
Growth susceptibility to hydrogen
peroxide may be a useful assay to
assess Cox1 translation under cer-
tain conditions when CcO assembly
is stalled from defects arising at the
IM/IMS interface.
Insertion of Cox1, Cox2, and Cox3 in the IM requires the
translocation of polypeptide segments across the IM by the
translocases, OxaI and Cox18 (39–41). The lack of sensitivity
to hydrogen peroxide observed in oxa1 and cox18 strains
suggests that both translocases are important for Cox1 inser-
tion. Both translocases arewell established to function onCox2,
but if Cox2were their only substrate, the clear prediction is that
the null mutants would accumulate the pro-oxidant Cox1
intermediate and become peroxide-sensitive.
Recently, a truncated Cox1 polypeptide was reported to
form in cells lackingMss51 (42). This novel 15-kDa polypep-
tide mp15 is not the pro-oxidant Cox1 intermediate dis-
cussed presently, since the mp15 polypeptide also forms in
shy1 and cox17 cells that are resistant to hydrogen perox-
ide (data not shown).
The peroxide sensitivity of sco1 cells is suppressed by either
wild-type Sco1, mutant Sco1 lacking the ability to bind Cu(I),
or human Sco1. Neither the copper-binding mutants nor
human Sco1 is competent to restore respiration to sco1 cells,
but they are able to suppress the peroxide sensitivity, again
highlighting the disconnection between respiration and perox-
ide sensitivity. The transmembrane domain of Sco1 is impor-
tant for peroxide resistance. Like Cox11, Sco1 may have a pro-
tein chaperone role in the assembly of CcO. The suppression of
peroxide sensitivity of sco1 cells by mutant Sco1 may arise
from a stabilizing effect of Sco1 on Cox2 in occluding the puta-
tive solvent channel in Cox1.
No redox function has been confirmed in Sco proteins. Sco
proteins in prokaryotes can have a function independent of
CuA site formation, since a number of bacterial species lacking
CuA CcO proteins have Sco homologs. Neisseria contain a Sco
protein that is not essential for maturation of the cbb3 oxidase
(43). Neisseria cells lacking this Sco protein are sensitive to
FIGURE 9.Overexpression of AFG1 in cox11 cells increases degradation of newly synthesized CcO sub-
units.Wild-type (WT), cox11, or cox11 cells overexpressing AFG1were radiolabeledwith [35S]methionine at
30 °C for 30 min in the presence of cycloheximide. Reaction has been stopped by the addition of an excess of
unlabeled methionine. A, labeling of Cox1, Cox2, and Cox3 and Cob1 in wild-type, cox11, or cox11 cells
overexpressingAFG1 is shownduring thepulsephase. The actual labelingof Cox1 in cox11 cellswasonly 67%
of that of wild-type cells. B–E, each reactionmixture was split into four parts that were incubated at 37 °C for 0,
10, 30, and 60 min, respectively. Cells were trichloroacetic acid-precipitated and subjected to SDS-PAGE and
autoradiography. Degradation kinetics of newly synthesized Cox1 (B), Cox2 (C), Cox3 (D), and Cob1 (E) proteins
was evaluated by densitometry. Degradation is assessed as a percentage of 35S radioactivity in each band
during the chase to the pulse time.
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paraquat (43). If the deletion strain accumulates a hemeB inter-
mediate of the cbb3 oxidase, a similar mechanism may confer
oxidative stress.
Themitochondrial Afg1 ATPase was found to be an efficient
suppressor of the peroxide sensitivity of CcO assembly
mutants. Afg1 was an inefficient suppressor of the peroxide
sensitivity of ccp1 and unable to suppress ctt1 cells, suggest-
ing some specificity. Although Afg1 lacks the zinc protease
domain of the AAA proteases of the mitochondria (Yme1 and
Yta10/Yta12), it does mediate the degradation of unassembled
Cox1, Cox2, and Cox3 polypeptides in cox11 cells. Afg1 local-
izes to the IM and may collaborate with a protease(s) for the
extrusion and degradation of unassembled subunits. Themp15
Cox1 truncate is degraded by the Yta10/Yta12 protease (42),
suggesting that Yta10/Yta12 may mediate the degradation
stimulated by Afg1.
Afg1 is a highly conserved eukaryotic protein with a robust
human homolog (supplemental Fig. 2). The similarity of Afg1
with the Cdc48 (p97) suggests that Afg1 forms a homohexam-
eric ring (44, 45). Yeast Cdc48 functions as an unfolding chap-
erone for the degradation of endoplasmic reticulummembrane
proteins by the proteasome. The mammalian p97 stimulates
the degradation of polytopic membrane proteins through
extraction of the protein from the endoplasmic reticulum
membrane (46). Likewise, Afg1 may function in the extraction
of mitochondrial IM proteins, including Cox1, and subsequent
presentation to a protease(s). Cdc48 interacts with a number of
adapter proteins that modulate its function. Afg1 may also
interact with adapter proteins as well as the actual protease.
Future studies will attempt to identify interacting partners of
Afg1.
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Supplement 
Fig. s1 Panel A. Serial dilutions of afg1_ cells harboring an empty vector or plasmid 
expressing AFG1 were spotted onto plates with either complete or synthetic media 
containing 2% glucose or 2% lactate/glycerol as a carbon source. Panel B. Cytochrome c 
oxidase and SDH/bc1 activities. Activities of the wild-type mitochondria were set as 100%. 
 
Fig. s2 Alignment of Afg1 proteins from different organisms. Highly conserved Walker A motif 
is underlined and marked by an asterisk. 

Fig. s2
Table 1
List of strains used in this study. Resgen signifies strains purchased from Research Genetics.
Strain Allele Source
WT BY4741 MATa his31 leu20 met150 ura30 rho+ Resgen
WT W303 MATa ura3-1 ade2-1 trp1-1 his3-11,15 leu2-3,112 rho+
WT NB80 MATa lys2 arg8::hisG ura3-52 leu2-3,112 his3-HindIII rho+ (1)
cox11 W303 MATa ura3-1 ade2-1 trp1-1 his3-11,15 leu2-3,112 cox11::HIS3 rho+ (2)
cox11 BY4741 MATa, his31, leu20, met150, ura30 cox11::kanMX rho+ Resgen
sco1 W303 MATa ura3-1 ade2-1 trp1-1 his3-11,15 leu2-3,112 sco1::URA3 rho+ (3)
sco1 BY4741 MATa his31 leu20 met150 ura30 sco1:: kanMX4 rho+ Resgen
cox1 NB80 MATa lys2 arg8::hisG ura3-52 leu2-3,112 his3-HindIII cox1::ARG8m rho+ (4)
cox2 NB80 MATa lys2 arg8::hisG ura3-52 leu2-3,112 his3-HindIII cox2-62 rho+ (1)
cox3 NB40 MATa arg8::URA3 ura30 leu2-3,112 his4-519 cox3::ARG8m rho+ (5)
pet309 BY4741 MATa his31 leu20 met150 ura30 pet309:: kanMX4 rho+ Resgen
pet111 BY4741 MATa his31 leu20 met150 ura30 pet111:: kanMX4 rho+ Resgen
cox10 W303 MATa ura3-1 ade2-1 trp1-1 his3-11,15 leu2-3,112 cox10::HIS3 rho+ (6)
cox10 BY4741 MATa, his31, leu20, met150, ura30 cox10::kanMX rho+ Resgen
cox20 BY4741 MATa, his31, leu20, met150, ura30 cox20::kanMX rho+ Resgen
ccp1 BY4741 MATa, his31, leu20, met150, ura30 ccp1::kanMX rho+ Resgen
ctt1 BY4741 MATa, his31, leu20, met150, ura30 ctt1::kanMX rho+ Resgen
afg1 BY4741 MATa, his31, leu20, met150, ura30 afg1::kanMX rho+ Resgen
cox14 BY4741 MATa, his31, leu20, met150, ura30 cox14::kanMX rho+ Resgen
cox11 cox14 BY4741 MATa, his31, leu20, met150, ura30 cox11::kanMX cox14::CaURA3 rho+ This study
cox11 pet309 BY4741 MATa, his31, leu20, met150, ura30 cox11::kanMX pet309::CaURA3 rho+ This study
shy1 W303 MATa ura3-1 ade2-1 trp1-1 his3-11,15 leu2-3,112 shy1::URA3 rho+ (7)
shy1 BY4741 MATa, his31, leu20, met150, ura30 shy1::kanMX rho+ Resgen
cox18 BY4741 MATa, his31, leu20, met150, ura30 cox18::kanMX rho+ Resgen
oxa1 BY4741 MATa, his31, leu20, met150, ura30 oxa1::kanMX rho+ Resgen
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